OSTEONIC Co., Ltd. (KOSDAQ:226400)
South Korea · Delayed Price · Currency is KRW 4,170.00
+20.00 (0.48%)
At close: Oct 23, 2026
OSTEONIC Revenue
OSTEONIC had revenue of 13.18B KRW in the quarter ending June 30, 2026, with 20.10% growth. This brings the company's total for the last twelve months to 50.97B, up 32.74% year-over-year. In the year 2025, OSTEONIC had annual revenue of 45.39B with 32.59% growth. That makes OSTEONIC the 29,746th largest company in the world by revenue and 1,854th in South Korea.
Revenue (ttm)
50.97B
Revenue Growth
+32.74%
P/S Ratio
1.64
Revenue / Employee
248.64M
Employees
205
Market Cap
83.66B
Revenue by Geography
- South Korea 23.87B 52.6%
- North America 5.85B 12.9%
- South America 4.74B 10.4%
- Asia 3.99B 8.8%
- Europe 3.96B 8.7%
- Middle East 2.19B 4.8%
- Oceania 610.04M 1.3%
- Africa 197.88M 0.4%
Fiscal year ended Dec 31, 2025 See the full OSTEONIC breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 45.39B | 11.16B | 32.59% |
| Dec 31, 2024 | 34.23B | 6.44B | 23.15% |
| Dec 31, 2023 | 27.80B | 7.96B | 40.12% |
| Dec 31, 2022 | 19.84B | 4.24B | 27.19% |
| Dec 31, 2021 | 15.60B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| KM Corporation | 144.10B |
| JW Shinyak | 81.04B |
| Sewoon Medical | 66.53B |
| CG MedTech | 51.20B |
| DuChemBIO | 41.51B |
| Wonbiogen | 37.80B |
| SCL Science | 30.50B |
| Plasmapp | 12.02B |